Sagimet Biosciences (SGMT) Other Working Capital Changes (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly Other Working Capital Changes came in at -$39000.0 in Q1 2026, little changed year-on-year from -$39000.0 in Q1 2025, and down 5.41% quarter-over-quarter from -$37000.0 in Q4 2025.
Sagimet Biosciences (SGMT) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$39000.0 for Q1 2026.
- On a quarterly basis, Other Working Capital Changes changed 0.0% year-over-year to -$39000.0 in Q1 2026; TTM through Mar 2026 was -$152000.0, a 11.76% decrease from a year earlier, with the FY2025 full-year figure at -$152000.0, down 11.76% from the prior year.
- Other Working Capital Changes eased to -$39000.0 in Q1 2026 per SGMT's latest filing, from -$37000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $4.3 million in Q3 2024 and bottomed at -$3.3 million in Q4 2024.
- The 5-year median for Other Working Capital Changes is $121000.0 (2022), against an average of $206333.3.
- Across the five-year window, Other Working Capital Changes soared 38.89% in 2024 and tumbled 77.27% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$34000.0 in 2022, then declined by 11.76% to -$38000.0 in 2023, then changed by 0.0% to -$38000.0 in 2024, then advanced by 2.63% to -$37000.0 in 2025, then decreased by 5.41% to -$39000.0 in 2026.
- Per Business Quant, the three latest SGMT Other Working Capital Changes figures stand at -$39000.0 (Q1 2026), -$37000.0 (Q4 2025), and -$37000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39,000.00 |
| Mar 31, 2026 | -39,000.00 |
| Mar 31, 2026 | -39,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Dec 31, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Mar 31, 2025 | -39,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Dec 31, 2024 | -38,000.00 |
| Sep 30, 2024 | -37,000.00 |
| Sep 30, 2024 | -37,000.00 |